Last edition
News about "Biologics Manufacturing "
Formycon and OneSource Partner to Manufacture Biosimilars
Formycon and OneSource Specialty Pharma have partnered to manufacture biosimilars, with OneSource providing integrated Drug Substance (DS) and Drug Product (DP) manufacturing from its Bengaluru biologics facility.
Biologics Manufacturing | 15/07/2026 | By News Bureau | 107
Shantha Biologics Announces Strategic Cartridge Fill-Finish Collaboration
Shantha Biologics has announced a cartridge fill-finish collaboration with Novo Nordisk, strengthening high-quality biologics manufacturing and global healthcare partnerships.
Biologics Manufacturing | 04/07/2026 | By News Bureau
WuXi Biologics Receives Brazil GMP Certification for Cancer Therapy Manufacturing
WuXi Biologics has received Brazil ANVISA GMP certification with zero inspection findings, enabling global commercial manufacturing of its innovative cancer immunotherapy.
Biologics Manufacturing | 02/07/2026 | By News Bureau
Shilpa Biologicals Commissions ADC Drug Substance GMP Facility in India
Shilpa Biologicals has launched an integrated Antibody Drug Conjugate (ADC) drug substance GMP facility in India, expanding Shilpa Medicare’s 25+ years of expertise in highly potent compound manufacturing.
Biologics Manufacturing | 26/06/2026 | By News Bureau
WuXi Biologics Secures South Korea GMP Certification for Key Manufacturing Facilities
The South Korea GMP Certification from the Ministry of Food and Drug Safety strengthens WuXi Biologics’ end-to-end capabilities for commercial production of complex biologics, including cancer therapies.
Biologics Manufacturing | 23/04/2026 | By News Bureau | 130
Strategic Alliance Targets Faster, High-Yield Biologics Manufacturing
OneCyte and Kemp Proteins have announced a strategic partnership to deliver advanced cell line development solutions for biopharmaceutical companies globally.
Biologics Manufacturing | 06/04/2026 | By Darshana | 175
Dupixent Approval in Japan Boosts Biologics Manufacturing Demand for Sanofi and Regeneron
The Ministry of Health, Labour and Welfare has granted marketing and manufacturing authorization to Dupixent (dupilumab) for the treatment of adults with moderate-to-severe bullous pemphigoid (BP), a rare and debilitating skin disorder.
Biologics Manufacturing | 25/03/2026 | By Darshana | 188
Thermo Fisher Opens Bioprocess Design Center in Hyderabad to Boost Biologics Manufacturing
Thermo Fisher Scientific has launched a new Bioprocess Design Center in Hyderabad to support India’s growing biologics and biopharmaceutical manufacturing ecosystem. The facility aims to help companies accelerate the development and scale-up of biologics, vaccines, and advanced therapies.
Biologics Manufacturing | 25/11/2025 | By Darshana | 315
AstraZeneca Plans USD 2 Billion Manufacturing Investment in Maryland
AstraZeneca will invest USD 2 billion to expand its biologics manufacturing in Maryland, boosting production of cancer, rare disease, and chronic therapies while supporting around 2,600 jobs.
Biologics Manufacturing | 24/11/2025 | By Dineshwori | 188
AbbVie has begun a USD 70 million expansion of its AbbVie Bioresearch Center (ABC) in Worcester, Massachusetts, and broken ground on a new North Chicago Active Pharmaceutical Ingredient (API) manufacturing facility.
Biologics Manufacturing | 01/10/2025 | By Dineshwori | 313
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy